KhabarCheckखबर चेक
← Top Stories

Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?

Partially corroborated51

ET Intelligence Group: Molbio Diagnostics, a molecular diagnostics manufacturer, plans to raise ₹200 crore through a fresh issue for capital expenditure. It will also raise ₹740 crore through an offer for sale. The promoter group's stake will fall to 43% after the IPO from 46.6%. The company oper...

First seen · latest update · India · business

  • Indian mainstream 1
  • Indian independent 0
  • International 0
  • Official 0
Share

Coverage (1)

See a mistake? Wrong summary · Wrongly grouped · Missing source · Wrong category/region · Dispute outlet rating — each opens a pre-filled report on GitHub.